Combination Therapy: New Hope For Combating Lung Cancer
Researchers at the Francis Crick Institute have achieved a breakthrough in lung cancer treatment by combining therapies to target resistant tumors. Their study on mice using KRAS G12C and SHP2 inhibitors, along with immunotherapy, demonstrated tumor sensitivity to treatment, offering hope for human application in overcoming drug resistance and enhancing efficacy.